Mass spectrometry analysis of the post-translational modifications of r-enolase from pancreatic ductal adenocarcinoma cells

Journal of Proteome Research

Volumn 9, Issue 6, 2010, Pages 2929-2936

  Zhou, Weidong ^a   Capello, Michela ^b,c   Fredolini, Claudia ^b,c   Piemonti, Lorenzo ^d   Liotta, Lance A ^a   Novelli, Francesco ^b,c   Petricoin, Emanuel F ^a  

^a GEORGE MASON UNIVERSITY   (United States)

^b MOLINETTE HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

acetylation; enolase; LTQ Orbitrap; mass spectrometry; methylation; pancreatic ductal adenocarcinoma; phosphorylation; post translational modification

Indexed keywords

ALPHA ENOLASE; ASPARTIC ACID; GLUTAMIC ACID; LYSINE;

ACETYLATION; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; METHYLATION; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL;

ACETYLATION; AMINO ACID SEQUENCE; CARCINOMA, PANCREATIC DUCTAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; METHYLATION; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; PHOSPHOPYRUVATE HYDRATASE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; TANDEM MASS SPECTROMETRY;

EID: 77954565511     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr901109w     Document Type: Article

References (41)

1. Pancholi, V. Multifunctional R-enolase: its role in diseases. Cell. Mol. Life Sci. 2001, 58 (7), 902-920.
2. Brewer, J. M. Specificity and mechanism of action of metal ions in yeast enolase. FEBS Lett. 1985, 182, 8-14.
3. Marangos, P. J.; Zis, A. P.; Clark, R. L.; Goodwin, F. K. Neuronal, non-neuronal and hybrid forms of enolase in brain: structural, immunological and functional comparisons. Brain Res. 1978, 150, 117-133.
4. Fletcher, L.; Rider, C. C.; Taylor, C. B. Enolase isoenzymes. III. Chromatographic and immunological characteristics of rat brain enolase. Biochim. Biophys. Acta 1976, 452, 245-252.
5. Kato, K.; Asai, R.; Shimizu, A.; Suzuki, F.; Ariyoshi, Y. Immunoassay of three enolase isozymes in human serum and in blood cells. Clin. Chim. Acta 1983, 127, 353-363.
6. Royds, J. A.; Parsons, M. A.; Taylor, C. B.; Timperley, W. R. Enolase isoenzyme distribution in the human brain and its tumours. J. Pathol. 1982, 137, 37-49.
7. Lebioda, L.; Stec, B. Crystal structure of enolase indicates that enolase and pyruvate kinase evolved from a common ancestor. Nature 1988, 333, 683-686.
8. Zhang, E.; Brewer, J. M.; Minor, W.; Carreira, L. A.; Lebioda, L. Mechanism of enolase: the crystal structure of asymmetric dimer enolase-2-phospho-D-glycerate/enolasephosphoenolpyruvate at 2.0 Å resolution. Biochemistry 1997, 36, 12526-12534.
9. Kang, H. J.; Jung, S. K.; Kim, S. J.; Chung, S. J. Structure of human alpha-enolase (hENO1), a multifunctional glycolytic enzyme. Acta Crystallogr. D Biol. Crystallogr. 2008, 64 (Pt 6):), 651-657.
10. Feo, S.; Arcuri, D.; Piddini, E.; Passantino, R.; Giallongo, A. ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1). FEBS Lett. 2000, 473, 47-52.
11. Miles, L. A.; Dahlberg, C. M.; Plescia, J.; Felez, J.; Kato, K.; Plow, E. F. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolases as a candidate plasminogen receptor. Biochemistry 1991, 30, 1682-1691.
12. Nakajima, K.; Hamanoue, M.; Takemoto, N.; Hattori, T.; Kato, K.; Kohsaka, S. Plasminogen binds specifically to a alpha-enolase on rat neuronal plasma membrane. J. Neurochem. 1994, 63, 2048-2057.
13. Dudani, A. K.; Cummings, C.; Hashemi, S.; Ganz, P. R. Isolation of a novel 45 kDa plasminogen receptor from human endothelial cells. Thromb. Res. 1993, 69, 185-196.
14. Redlitz, A.; Fowler, B. J.; Plow, E. F.; Miles, L. A. The role of an enolase-related molecule in plasminogen binding to cells. Eur. J. Biochem. 1995, 227, 407-415.
15. Fontan, P. A.; Pancholi, V.; Nociari, M. M.; Fischetti, V. A. Antibodies to streptococcal surface enolase react with human a-enolase: implications in poststreptococcal sequelae. J. Infect. Dis. 2000, 182, 1712-1721.
16. Eriksson, B.; Oberg, K.; Stridsberg, M. Tumor markers in neuroendocrine tumors. Digestion 2000, 62, S33-S38.
17. Niklinski, J.; Furman, M. Clinical tumour markers in lung cancer. Eur. J. Cancer Prev. 1995, 4, 129-138.
18. Cooper, E. H. Neuron-specific enolase. Int. J. Biol. Markers 1994, 9, 205-210.
19. Ledermann, J. A. Serum neurone-specific enolase and other neuroendocrine markers in lung cancer. Eur. J. Cancer 1994, 30A, 574-576.
20. Ebert, W.; Muley, T.; Drings, P. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process. Anticancer Res. 1996, 16, 2161-2168.
21. Kaiser, E.; Kuzmits, R.; Pregant, P.; Burghuber, O.; Worofka, W. Clinical biochemistry of neuron specific enolase. Clin. Chim. Acta 1989, 183, 13-31.
22. Takashima, M.; Kuramitsu, Y.; Yokoyama, Y.; Iizuka, N.; Fujimoto, M.; Nishisaka, T.; Okita, K.; Oka, M.; Nakamura, K. Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis. Proteomics 2005, 5 (6), 1686-1692.
23. Cappello, P.; Tomaino, B.; Chiarle, R.; Ceruti, P.; Novarino, A.; Castagnoli, C.; Migliorini, P.; Perconti, G.; Giallongo, A.; Milella, M.; Monsurrò, V.; Barbi, S.; Scarpa, A.; Nisticò, P.; Giovarelli, M.; Novelli, F. An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen. Int. J. Cancer 2009, 125 (3):), 639-648.
24. Laheru, D.; Jaffee, E. M. Immunotherapy for pancreatic cancer-science driving clinical progress. Nat. Rev. Cancer 2005, 5, 459-467.
25. Tomaino, B.; Cappello, P.; Capello, M.; Fredolini, C.; Ponzetto, A.; Novarino, A.; Ciuffreda, L.; Bertetto, O.; De Angelis, C.; Gaia, E.; Salacone, P.; Milella, M.; Nisticò, P.; Alessio, M.; Chiarle, R.; Giuffrida, M. G.; Giovarelli, M.; Novelli, F. Autoantibody signature in human ductal pancreatic adenocarcinoma. J. Proteome Res. 2007, 6 (10), 4025-4031.
26. Shevchenko, A.; Jensen, O. N.; Podtelejnikov, A. V.; Sagliocco, F.; Wilm, M.; Vorm, O.; Mortensen, P.; Shevchenko, A.; Boucherie, H.; Mann, M. Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. Proc. Natl. Acad. Sci. USA 1996, 93 (25), 14440-14445.
27. Zhou, W.; Ross, M. M.; Tessitore, A.; Ornstein, D.; VanMeter, A.; Liotta, L. A.; Petricoin, E. F. An Initial Characterization of the Serum Phosphoproteome. J. Proteome Res. 2009, 8 (12), 5523-5531.
28. Elias, J. E.; Gygi, S. P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 2007, 4 (3), 207-214.
29. Walsh, C. T. Posttranslational modification of proteins; Roberts & Company Publishers: Greenwood Village, CO, 2007.
30. Eigenbrodt, E.; Fister, P.; Rübsamen, H.; Friis, R. R. Influence of transformation by Rous sarcoma virus on the amount, phosphorylation and enzyme kinetic properties of enolase. EMBO J. 1983, 2 (9), 1565-1570.
31. Bottalico, L. A.; Kendrick, N. C.; Keller, A.; Li, Y.; Tabas, I. Cholesteryl ester loading of mouse peritoneal macrophages is associated with changes in the expression or modification of specific cellular proteins, including increase in an a-enolase isoform. Arterioscl. Thromb. 1993, 13, 264-275.
32. Rush, J.; Moritz, A.; Lee, K. A.; Guo, A.; Goss, V. L.; Spek, E. J.; Zhang, H.; Zha, X. M.; Polakiewicz, R. D.; Comb, M. J. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 2005, 23, 94-101.
33. Kim, S. C.; Sprung, R.; Chen, Y.; Xu, Y.; Ball, H.; Pei, J.; Cheng, T.; Kho, Y.; Xiao, H.; Xiao, L.; Grishin, N. V.; White, M.; Yang, X. J.; Zhao, Y. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 2006, 23, 607-618.
34. Rikova, K.; Guo, A.; Zeng, Q.; Possemato, A.; Yu, J.; Haack, H.; Nordone, J.; Lee, K.; Reeves, C.; Li, Y.; Hu, Y.; Tan, Z.; Stokes, M.; Sullivan, L.; Mitchell, J.; Wetzek, R.; Macneill, J.; Ren, J. M. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007, 131, 1190-1203.
35. Yu, L. R.; Zhu, Z.; Chan, K. C.; Issaq, H. J.; Dimitrov, D. S.; Veenstra, T. D. Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra. J. Proteome Res. 2007, 6, 4150-4162.
36. Molina, H.; Horn, D. M.; Tang, N.; Mathivanan, S.; Pandey, A. Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 2007, 104, 2199-2204.
37. Dephoure, N.; Zhou, C.; Villen, J.; Beausoleil, S. A.; Bakalarski, C. E.; Elledge, S. J.; Gygi, S. P. A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. USA 2008, 105, 10762-10767.
38. Mayya, V.; Lundgren, D. H.; Hwang, S. I.; Rezaul, K.; Wu, L.; Eng, J. K.; Rodionov, V.; Han, D. K. Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci. Signal 2009, 2, RA46-RA46.
39. Choudhary, C.; Kumar, C.; Gnad, F.; Nielsen, M. L.; Rehman, M.; Walther, T. C.; Olsen, J. V.; Mann, M. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009, 325 (5942), 834-840.
40. Hunter, T. Signalings 2000 and beyond. Cell 2000, 100 (1), 113-127.
41. Zhao, S.; Xu, W.; Jiang, W.; Yu, W.; Lin, Y.; Zhang, T.; Yao, J.; Zhou, L.; Zeng, Y.; Li, H.; Li, Y.; Shi, J.; An, W.; Hancock, S. M.; He, F.; Qin, L.; Chin, J.; Yang, P.; Chen, X.; Lei, Q.; Xiong, Y.; Guan, K. L. Regulation of cellular metabolism by protein lysine acetylation. Science 2010, 327 (5968), 964-965.